Skip to main navigation

Our Company
Development Pipeline
Investor Relations
Medical Professionals
Careers
Contact Us

Event Details

Home
Investor Relations
Events and Presentations
Event Details

DAY HI:

DAY LOW:

VOLUME:

Copyright West LLC. Minimum 15 minutes delayed.

Shareholder Tools

Printed Materials
Email Alerts
Download Library
RSS Feeds
Print

Spectrum Pharmaceuticals 1Q 2016 Earnings Call

May 5, 2016 at 4:30 PM EDT

Listen to webcast

Our Company

Company Philosophy
Corporate Compliance
Partnerships
Management
Board of Directors
Careers

Development Pipeline

Pipeline
ROLONTIS® (eflapegrastim)
Poziotinib
Glossary

Investor Relations

Press Releases
Events and Presentations
Corporate Governance
Annual Report and Proxy Information
Financial Information
Stock Information
Investor FAQs

Medical Professionals

Clinical Trials
Medical Affairs
Grants
Investigator Initiated Trials

Careers

Contact Us

This Web site contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and in reliance upon the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on the beliefs of the Company's management as well as assumptions made by and information currently available to the Company's management. Readers should not put undue reliance on these forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Spectrum Pharmaceuticals, Inc.'s actual results may differ materially from the results projected in the forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed in the Company's most recent Form 10-K and 10-Qs. We do not plan to update any such forward-looking statements and expressly disclaim any duty to update the information contained in this filing except as required by law.

All contents copyright Spectrum Pharmaceuticals, Inc. © 2019.
All Rights Reserved. PP-ALL-00-0021

Site Map
Privacy Policy
Terms of Use
Linking Policy
Contact Us

Remote Support
Webmail